Substituted morpholine compounds for the treatment of central nervous system disorders

This invention relates to compounds of the formulae I wherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

Saved in:
Bibliographic Details
Main Authors GRAY DAVID L, BARTA NANCY S, GLASE SHELLY ANN, SIMONS LLOYD JEROME, XU WENIJAN, REICHARD GREGORY A
Format Patent
LanguageEnglish
Published 09.02.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This invention relates to compounds of the formulae I wherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Bibliography:Application Number: US20050119210